The global cannabis pharmaceuticals market is poised for exponential growth, with projections indicating an increase from $3.46 billion in 2023 to $380.77 billion by 2034. This remarkable expansion, ...

The Global Marijuana market has experienced remarkable growth over recent years, driven by changing regulations, increasing acceptance of cannabis ...

Q2 2025 Earnings Call Transcript January 9, 2025 Operator: Thank you for joining us for today’s conference call to discuss ...

Tilray cultivates and sells cannabis in Canada and exports into the global medical market. It also sells CBD and alcohol. The company is the result of legacy Aphria acquiring legacy Tilray in a ...

Guidance for Fiscal 2025: Anticipated net revenues between $950 million and $1 billion. Tilray Brands Inc (NASDAQ:TLRY) reported a 9% year-over-year increase in net revenue, reaching $211 million for ...

Thank you for joining us for today's conference call to discuss Tilray Brands' financial results for the second quarter ended November 30th, 2024. All ...

Tilray Brands (NASDAQ: TLRY) stock tumbled 12% through 9:50 a.m. ET after missing analyst sales forecasts in its Friday morning report. Heading into the news, Wall Street analysts anticipated ...

Thank you for joining us for today's conference call to discuss Tilray Brands' financial results for the second quarter ended November 30th, 2024. All lines have been placed on mute to prevent any ...

Tilray Brands logged a wider loss in its fiscal second quarter and said revenue rose after sales at its beverage business offset declines at its core cannabis unit The cannabis-lifestyle and ...

Tilray Brands, Inc. ("Tilray”, "our”, "we” or the "Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company leading the forefront of beverage, cannabis and wellness ...